MindBio Therapeutics Corp. (CSE:MBIO)
Canada · Delayed Price · Currency is CAD 0.2500
0.00 (0.00%)
At close: Aug 10, 2026
MindBio Therapeutics Market Cap
MindBio Therapeutics has a market cap or net worth of CAD 1.82 million as of August 10, 2026. Its market cap has decreased by -73.41% in one year.
Market Cap
1.82M
Enterprise Value
3.84M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
ChartMarket Cap Chart
Since May 5, 2023, MindBio Therapeutics's market cap has decreased from 79.83M to 1.82M, a decrease of -97.72%. That is a compound annual growth rate of -68.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 1.82M | -69.62% |
| Dec 31, 2025 | 5.99M | 109.60% |
| Dec 31, 2024 | 2.86M | -14.04% |
| Dec 27, 2023 | 3.33M | -95.83% |
| May 5, 2023 | 79.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innovotech | 4.63M |
| Restart Life Sciences | 4.36M |
| Grey Matters Health | 3.61M |
| Quest PharmaTech | 3.38M |
| Rakovina Therapeutics | 3.17M |
| BioVaxys Technology | 3.09M |
| ASEP Medical Holdings | 2.22M |
| Universal Ibogaine | 1.56M |